Does OBINUTUZUMAB Cause Haemorrhage? 373 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 373 reports of Haemorrhage have been filed in association with OBINUTUZUMAB (Gazyva). This represents 2.6% of all adverse event reports for OBINUTUZUMAB.
373
Reports of Haemorrhage with OBINUTUZUMAB
2.6%
of all OBINUTUZUMAB reports
19
Deaths
12
Hospitalizations
How Dangerous Is Haemorrhage From OBINUTUZUMAB?
Of the 373 reports, 19 (5.1%) resulted in death, 12 (3.2%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Haemorrhage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 373 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Haemorrhage?
RIVAROXABAN (6,571)
APIXABAN (4,770)
EMICIZUMAB-KXWH (3,612)
WARFARIN (2,930)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (2,925)
ASPIRIN (2,878)
ADALIMUMAB (2,681)
IBRUTINIB (1,907)
CLOPIDOGREL BISULFATE (1,762)
INSULIN LISPRO (1,614)
Which OBINUTUZUMAB Alternatives Have Lower Haemorrhage Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE